Skip to main content
Erschienen in: Abdominal Radiology 8/2021

27.04.2021 | Special Section : HCC Treatment

Role of the radiologist at HCC multidisciplinary conference and use of the LR-TR algorithm for improving workflow

verfasst von: Anuradha S. Shenoy-Bhangle, Leo L. Tsai, Mark Masciocchi, Sandeep Singh Arora, Ania Z. Kielar

Erschienen in: Abdominal Radiology | Ausgabe 8/2021

Einloggen, um Zugang zu erhalten

Abstract

Multidisciplinary conferences (MDCs) play a major role in management and care of oncology patients. Hepatocellular carcinoma (HCC) is a complex disease benefiting from multidisciplinary discussions to determine optimal patient management. A multitude of liver-directed locoregional therapies have emerged allowing for more options for treatment of HCC. A radiologist dedicated to HCC-MDC is an important member of the team contributing to patient care in multiple ways. The radiologist plays a key role in image interpretation guiding initial therapy discussions as well as interpreting post-treatment imaging following liver-directed therapy. Standardization of image interpretation can lead to more consistent treatment received by the patient as well as accurate assessment of transplant eligibility. The radiologist can facilitate this process using structured reporting that is also supported by stakeholders involved in interdisciplinary management of liver diseases. The Liver Imaging Reporting and Data System (LI-RADS), is a living document which offers a standardized reporting algorithm for consistent communication of radiologic findings for HCC screening and characterization of liver observations in patients at risk for HCC. The LI-RADS post-treatment algorithm (LR-TR algorithm) has been developed to standardize liver observations following liver-directed locoregional therapy. This review article focuses on the role of the radiologist at HCC-MDC and implementation of the LR-TR algorithm for improving workflow.
Literatur
2.
Zurück zum Zitat Gadsden MM, Kaplan DE. Multidisciplinary Approach to HCC Management: How Can This Be Done? Dig Dis Sci. 2019;64(4):968-975 Gadsden MM, Kaplan DE. Multidisciplinary Approach to HCC Management: How Can This Be Done? Dig Dis Sci. 2019;64(4):968-975
3.
Zurück zum Zitat Chang TT, Sawhney R, Monto A, Davoren JB, Kirkland JG, Steward L, et al. Implementation of a multidisciplinary treatment team for hepatocellular cancer at a Veterans Affairs Medical Center improves survival. HPB (Oxford). 2008; 10:405-11 Chang TT, Sawhney R, Monto A, Davoren JB, Kirkland JG, Steward L, et al. Implementation of a multidisciplinary treatment team for hepatocellular cancer at a Veterans Affairs Medical Center improves survival. HPB (Oxford). 2008; 10:405-11
4.
Zurück zum Zitat Yopp AC, Mansour JC, Beg MS, et al. Establishment of a multidisciplinary hepatocellular carcinoma clinic is associated with improved clinical outcome. Ann Surg Oncol. 2014;21(4):1287-1295. Yopp AC, Mansour JC, Beg MS, et al. Establishment of a multidisciplinary hepatocellular carcinoma clinic is associated with improved clinical outcome. Ann Surg Oncol. 2014;21(4):1287-1295.
5.
Zurück zum Zitat Sinn DH, Choi GS, Park HC, Kim JM, Kim H, et al. (2019) Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients. PLOS ONE 14(1): e0210730. Sinn DH, Choi GS, Park HC, Kim JM, Kim H, et al. (2019) Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients. PLOS ONE 14(1): e0210730.
6.
Zurück zum Zitat Charriere, B.; Muscari, F.; Maulat, C.; Bournet, B.; Bonnet, D.; Bureau, C.; Otal, P.; Peron, J.M.; Suc, B. Outcomes of patients with hepatocellular carcinoma are determined in multidisciplinary team meetings. J. Surg. Oncol. 2017, 115, 330–336. Charriere, B.; Muscari, F.; Maulat, C.; Bournet, B.; Bonnet, D.; Bureau, C.; Otal, P.; Peron, J.M.; Suc, B. Outcomes of patients with hepatocellular carcinoma are determined in multidisciplinary team meetings. J. Surg. Oncol. 2017, 115, 330–336.
7.
Zurück zum Zitat Elsayes KM, Hooker JC, Agrons MM, et al. (2017) 2017 Version of LI-RADS for CT and MR Imaging: An Update. Radiographics. 37(7):1994–2017CrossRef Elsayes KM, Hooker JC, Agrons MM, et al. (2017) 2017 Version of LI-RADS for CT and MR Imaging: An Update. Radiographics. 37(7):1994–2017CrossRef
9.
Zurück zum Zitat Elsayes KM, Kielar AZ, Chernyak V, et al. LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance. J Hepatocell Carcinoma. 2019; 6:49–69. Elsayes KM, Kielar AZ, Chernyak V, et al. LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance. J Hepatocell Carcinoma. 2019; 6:49–69.
11.
Zurück zum Zitat Chernyak V, Fowler KJ, Kamaya A, et al. Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients. Radiology. 2018;289(3):816–830. Chernyak V, Fowler KJ, Kamaya A, et al. Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients. Radiology. 2018;289(3):816–830.
12.
Zurück zum Zitat Kielar A, Fowler KJ, Lewis S, et al. Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm. Abdom Radiol (NY). 2018;43(1):218–230. Kielar A, Fowler KJ, Lewis S, et al. Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm. Abdom Radiol (NY). 2018;43(1):218–230.
16.
Zurück zum Zitat Flusberg M, Ganeles J, Ekinci T, Goldberg-Stein S, Paroder V, Kobi M, Chernyak V. Impact of a Structured Report Template on the Quality of CT and MRI Reports for Hepatocellular Carcinoma Diagnosis. J Am Coll Radiol. 2017 Sep;14(9):1206-1211. https://doi.org/10.1016/j.jacr.2017.02.050. Epub 2017 May 6. PMID: 28483546. Flusberg M, Ganeles J, Ekinci T, Goldberg-Stein S, Paroder V, Kobi M, Chernyak V. Impact of a Structured Report Template on the Quality of CT and MRI Reports for Hepatocellular Carcinoma Diagnosis. J Am Coll Radiol. 2017 Sep;14(9):1206-1211. https://​doi.​org/​10.​1016/​j.​jacr.​2017.​02.​050. Epub 2017 May 6. PMID: 28483546.
17.
Zurück zum Zitat Poullos PD, Tseng JJ, Melcher ML, Concepcion W, Loening AM, Rosenberg J, Willmann JK. Structured Reporting of Multiphasic CT for Hepatocellular Carcinoma: Effect on Staging and Suitability for Transplant. AJR Am J Roentgenol. 2018 Apr;210(4):766-774. https://doi.org/10.2214/ajr.17.18725. Epub 2018 Feb 22. PMID: 29470153. Poullos PD, Tseng JJ, Melcher ML, Concepcion W, Loening AM, Rosenberg J, Willmann JK. Structured Reporting of Multiphasic CT for Hepatocellular Carcinoma: Effect on Staging and Suitability for Transplant. AJR Am J Roentgenol. 2018 Apr;210(4):766-774. https://​doi.​org/​10.​2214/​ajr.​17.​18725. Epub 2018 Feb 22. PMID: 29470153.
20.
Zurück zum Zitat Covey AM and Hussain SM. Liver-Directed Therapy for Hepatocellular Carcinoma: An Overview of Techniques, Outcomes, and Posttreatment Imaging Findings. AJR Am J Roentgenol 2017 209:1, 67-76 Covey AM and Hussain SM. Liver-Directed Therapy for Hepatocellular Carcinoma: An Overview of Techniques, Outcomes, and Posttreatment Imaging Findings. AJR Am J Roentgenol 2017 209:1, 67-76
21.
Zurück zum Zitat Shi W, He Y, Ding W, et al. (1064) Contrast-enhanced ultra- sonography used for post-treatment responses evaluation of radiofrequency ablations for hepatocellular carcinoma: a meta- analysis. Br J Radiol 2016(89):20150973 Shi W, He Y, Ding W, et al. (1064) Contrast-enhanced ultra- sonography used for post-treatment responses evaluation of radiofrequency ablations for hepatocellular carcinoma: a meta- analysis. Br J Radiol 2016(89):20150973
22.
Zurück zum Zitat Hunt SJ, et al. Radiologic monitoring of hepatocellular carcinoma tumor viability after transhepatic arterial chemoembolization: estimating the accuracy of contrast-enhanced cross-sectional imaging with histopathologic correlation. J Vasc Interv Radiol. 2009; 20(1):30–8. [PubMed: 19028117] Hunt SJ, et al. Radiologic monitoring of hepatocellular carcinoma tumor viability after transhepatic arterial chemoembolization: estimating the accuracy of contrast-enhanced cross-sectional imaging with histopathologic correlation. J Vasc Interv Radiol. 2009; 20(1):30–8. [PubMed: 19028117]
23.
Zurück zum Zitat Ehman EC, et al. Imaging prediction of residual hepatocellular carcinoma after locoregional therapy in patients undergoing liver transplantation or partial hepatectomy. Abdom Radiol (NY). 2016; 41(11):2161–2168. [PubMed: 27484789] Ehman EC, et al. Imaging prediction of residual hepatocellular carcinoma after locoregional therapy in patients undergoing liver transplantation or partial hepatectomy. Abdom Radiol (NY). 2016; 41(11):2161–2168. [PubMed: 27484789]
24.
26.
Zurück zum Zitat Chaudhry M, McGinty KA, Mervak B, Lerebours R, Li C, Shropshire E, Ronald J, Commander L, Hertel J, Luo S, Bashir MR, Burke LMB. The LI-RADS Version 2018 MRI Treatment Response Algorithm: Evaluation of Ablated Hepatocellular Carcinoma. Radiology. 2020 Feb;294(2):320-326. https://doi.org/10.1148/radiol.2019191581. Epub 2019 Dec 17. PMID: 31845843. Chaudhry M, McGinty KA, Mervak B, Lerebours R, Li C, Shropshire E, Ronald J, Commander L, Hertel J, Luo S, Bashir MR, Burke LMB. The LI-RADS Version 2018 MRI Treatment Response Algorithm: Evaluation of Ablated Hepatocellular Carcinoma. Radiology. 2020 Feb;294(2):320-326. https://​doi.​org/​10.​1148/​radiol.​2019191581. Epub 2019 Dec 17. PMID: 31845843.
27.
Zurück zum Zitat Yun Zhang, Jinju Wang, Hui Li, Tianying Zheng, Hanyu Jiang, Mou Li, Bin Song. Performance of LI-RADS version 2018 CT treatment response algorithm in tumor response evaluation and survival prediction of patients with single hepatocellular carcinoma after radiofrequency ablation. Ann Transl Med. 2020 Mar;8(6):388. https://doi.org/10.21037/atm.2020.03.120. Yun Zhang, Jinju Wang, Hui Li, Tianying Zheng, Hanyu Jiang, Mou Li, Bin Song. Performance of LI-RADS version 2018 CT treatment response algorithm in tumor response evaluation and survival prediction of patients with single hepatocellular carcinoma after radiofrequency ablation. Ann Transl Med. 2020 Mar;8(6):388. https://​doi.​org/​10.​21037/​atm.​2020.​03.​120.
Metadaten
Titel
Role of the radiologist at HCC multidisciplinary conference and use of the LR-TR algorithm for improving workflow
verfasst von
Anuradha S. Shenoy-Bhangle
Leo L. Tsai
Mark Masciocchi
Sandeep Singh Arora
Ania Z. Kielar
Publikationsdatum
27.04.2021
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 8/2021
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-021-03094-9

Weitere Artikel der Ausgabe 8/2021

Abdominal Radiology 8/2021 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.